Plasma fibrinogen gamma' chain content in the thrombotic microangiopathy syndrome. - Wikidata - wikimedia - TriplyDB

Plasma fibrinogen gamma' chain content in the thrombotic microangiopathy syndrome.

Plasma fibrinogen gamma' chain content in the thrombotic microangiopathy syndrome.

http://www.wikidata.org/entity/Q33372953

about

Assessment of genetic determinants of the association of γ' fibrinogen in relation to cardiovascular disease Association of Plasma γ' Fibrinogen With Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study.Primed to Understand Fibrinogen in Cardiovascular Disease Elevated prothrombin promotes venous, but not arterial, thrombosis in mice.The presence of gamma' chain impairs fibrin polymerization.Evidence that alpha2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation.Evidence that fibrinogen γ' directly interferes with protofibril growth: implications for fibrin structure and clot stiffness.Fibrinogen and Fibrin in Hemostasis and Thrombosis.

P2860

Q35216237-C5FA576A-B629-4B4A-85DA-010D8BCD2711 Q36326804-F8C4E73B-F6A6-4A52-9A17-E5C88CFD578B Q36407172-85F5C9A1-87B9-46AB-86C3-F9B97713A61C Q37189156-0530F6D3-B133-4D71-8D51-709F976D511B Q37363845-77BB2CBB-88A9-4DC0-A4D6-C6FCDE7000F2 Q41476888-B3F7FA87-8267-46E3-A1D2-21D1B90B64C2 Q52623827-226CD75E-6F2B-41A7-A85C-E38E595BD1A8 Q54842287-CA4BDA9B-0556-4FCB-A0FC-20E3F8D55B5D

P2860

Plasma fibrinogen gamma' chain content in the thrombotic microangiopathy syndrome.

http://www.wikidata.org/entity/Q33372953

description

2006 nî lūn-bûn

@nan

2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Plasma fibrinogen gamma' chain content in the thrombotic microangiopathy syndrome.

@ast

Plasma fibrinogen gamma' chain content in the thrombotic microangiopathy syndrome.

@en

type

label

Plasma fibrinogen gamma' chain content in the thrombotic microangiopathy syndrome.

@ast

Plasma fibrinogen gamma' chain content in the thrombotic microangiopathy syndrome.

@en

prefLabel

Plasma fibrinogen gamma' chain content in the thrombotic microangiopathy syndrome.

@ast

Plasma fibrinogen gamma' chain content in the thrombotic microangiopathy syndrome.

@en

P1433

Q33372953-AC0922E3-D355-4040-9263-ABF6B66C28E1

P1476

Q33372953-A54CBD64-4194-4E99-BB06-DFBD60DDA700

P2093

Q33372953-068A357C-195E-4689-B0A2-FD475F77A0B2

Q33372953-2C49B907-5A18-4E23-B4C5-42BE3DDAD9BF

Q33372953-4F7D4756-1D04-4201-9D60-06A65BED9ED7

Q33372953-C42F3FBF-284D-4402-8B10-8FE759748552

Q33372953-CA4D3359-FF8F-43AC-9812-2D9AC6148DFB

Q33372953-E9E1D7E4-AC45-42E4-960D-F2934F058DC5

P2860

Q33372953-0B551B5F-1402-44CF-A313-A38B8345B07F

Q33372953-14674239-3F4A-41FF-BC2B-E509D8AB7627

Q33372953-1714432A-E9D4-4656-9DC6-289B1001FB2B

Q33372953-1E46AA1F-54FA-4B11-AF3F-3776AA8CEF50

Q33372953-22F02F76-E0C3-42A0-9261-08888E568913

Q33372953-27346F12-E757-4358-98C6-794AEF4B3CD4

Q33372953-283700E1-1D9C-432A-BD27-FCBD7BC4B51F

Q33372953-2A97573F-CBE0-4B1F-A3D8-DDE043495BE6

Q33372953-311182CA-44FD-410F-9490-C09314E39E0B

Q33372953-34084F8E-6239-40BF-8375-A60BC750AE7E

P304

Q33372953-16973477-0367-4BFF-A080-76A784BAC99D

P31

Q33372953-9A2C175A-6824-43CC-A829-4E31C2154F1A

P356

Q33372953-08988C31-92C1-442D-ABA2-3DEEA5BFCEB3

P433

Q33372953-C2D1AF10-33B5-4B4C-8D65-40C5142C5ADA

P478

Q33372953-29EB45E0-053E-4488-97B4-C68A71D438EC

P50

Q33372953-329295D9-835D-4DFA-B285-2BD53DC52C12

Q33372953-62D9F93E-F3B0-4826-A7C0-C8DE120777EC

P577

Q33372953-4647D90D-A73A-481C-882A-1C3E7413C63E

P5875

Q33372953-EE23540A-BF75-449D-8B4C-5C81745E97B0

P698

Q33372953-3209FDA3-E27D-428D-96DA-BAC782655E0C

P356

J.1538-7836.2006.02270.X

P1433

Journal of Thrombosis and Haemostasis

P1476

Plasma fibrinogen gamma' chain content in the thrombotic microangiopathy syndrome

@en

P2093

I Hernandez

http://www.w3.org/2001/XMLSchema#string

M W Mosesson

http://www.w3.org/2001/XMLSchema#string

P J Simpson-Haidaris

http://www.w3.org/2001/XMLSchema#string

R M Bertina

http://www.w3.org/2001/XMLSchema#string

S Uitte DE Willige

http://www.w3.org/2001/XMLSchema#string

T J Raife

http://www.w3.org/2001/XMLSchema#string

P2860

Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases.

ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients.

Recent advances in thrombotic thrombocytopenic purpura.

Thrombotic thrombocytopenic purpura and its diagnosis.

The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency.

Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure.

Coagulation studies in thrombotic thrombocytopenic purpura, with special reference to von Willebrand factor and protein S.

Carboxyl-terminal amino acid sequences of two variant forms of the gamma chain of human plasma fibrinogen.

Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains.

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies.

P304

62-69

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1538-7836.2006.02270.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Sergiy Yakovlev

P577

2006-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6757595

http://www.w3.org/2001/XMLSchema#string

P698

17038160

http://www.w3.org/2001/XMLSchema#string